Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR -mutation-positive non-small-ce...
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR -mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
About this item
Full title
Author / Creator
Soria, Jean-Charles, Prof , Wu, Yi-Long, Prof , Nakagawa, Kazuhiko, Prof , Kim, Sang-We, Prof , Yang, Jin-Ji, MD , Ahn, Myung-Ju, Prof , Wang, Jie, MD , Yang, James Chih-Hsin, Prof , Lu, You, Prof , Atagi, Shinji, MD , Ponce, Santiago, MD , Lee, Dae Ho, Prof , Liu, Yunpeng, Prof , Yoh, Kiyotaka, MD , Zhou, Jian-Ying, Prof , Shi, Xiaojin, MD , Webster, Alan, MSc , Jiang, Haiyi, MD and Mok, Tony S K, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Optimum management strategies for patients with advanced non-small-cell lung cancer (NSCLC) with acquired resistance to EGFR tyrosine-kinase inhibitors are undefined. We aimed to assess the efficacy and safety of continuing gefitinib combined with chemotherapy versus chemotherapy alone in patients with EGFR -mutation-positive adv...
Alternative Titles
Full title
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR -mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
Authors, Artists and Contributors
Author / Creator
Wu, Yi-Long, Prof
Nakagawa, Kazuhiko, Prof
Kim, Sang-We, Prof
Yang, Jin-Ji, MD
Ahn, Myung-Ju, Prof
Wang, Jie, MD
Yang, James Chih-Hsin, Prof
Lu, You, Prof
Atagi, Shinji, MD
Ponce, Santiago, MD
Lee, Dae Ho, Prof
Liu, Yunpeng, Prof
Yoh, Kiyotaka, MD
Zhou, Jian-Ying, Prof
Shi, Xiaojin, MD
Webster, Alan, MSc
Jiang, Haiyi, MD
Mok, Tony S K, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1751230451
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751230451
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(15)00121-7
